Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2014
09/04/2014US20140248330 Device for transdermal administration of drugs including acrylic polymers
09/04/2014US20140248315 Methods and compositions for enhancing an immune response, blocking monocyte migration, amplifying vaccine immunity and inhibiting tumor growth and metastasis
09/04/2014US20140248292 Compositions and methods for treating cancer
09/04/2014US20140248291 Modulation of Cellular Migration
09/04/2014US20140248288 Biodegradable metal alloys
09/04/2014US20140248286 Anti-hemagglutinin antibodies and methods of use
09/04/2014US20140248280 Anti-erbb3 antibodies in combination with paclitaxel for treatment of gynecological cancers
09/04/2014US20140248274 Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies
09/04/2014US20140248268 Rab7 GTPase Inhibitors and Related Methods of Treatment
09/04/2014US20140248264 Small molecule trail gene induction by normal and tumor cells as an anticancer therapy
09/04/2014US20140248263 Bisphenol compounds and methods for their use
09/04/2014US20140248262 Combination therapy of a type ii anti-cd20 antibody with a selective bcl-2 inhibitor
09/04/2014US20140248253 Compositions and methods for the treatment of cns injuries
09/04/2014US20140248252 New Salt And Medical Use
09/04/2014US20140248247 Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease
09/04/2014US20140248242 Thiophosphate nucleosides for the treatment of hcv
09/04/2014US20140248241 3'-deoxy nucleosides for the treatment of hcv
09/04/2014US20140248240 Piperidine derivatives and compositions for the inhibition of nicotinamide phosphoribosyltransferase (nampt)
09/04/2014US20140248239 Triazine compounds as pi3 kinase and mtor inhibitors
09/04/2014US20140248236 Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction
09/04/2014US20140248233 Biocompatible composite materials
09/04/2014US20140248220 Foamable suspension gel
09/04/2014US20140248216 Drug delivery by carbon nanotube arrays
09/04/2014US20140248209 Anti-tumoral compound and relative production process
09/04/2014US20140246022 Nasal administration
09/03/2014EP2772544A1 Novel compound and method for producing same
09/03/2014EP2772541A2 Targeting opposite strand replication intermediates of hepatitis C virus by RNAi
09/03/2014EP2772540A1 Method for detecting specific single nucleotide polymorphism related to ankylosing spondylitis and kit therefor
09/03/2014EP2772522A1 Radical inhibitor
09/03/2014EP2772492A1 Use of an isoxazole derivative for the treatment of withdrawal symptom
09/03/2014EP2772491A1 Crystals of androgen receptor antagonist compound
09/03/2014EP2772490A1 Aminoalkyl-substituted n-thienyl benzamide derivative
09/03/2014EP2772486A1 Kinase inhibitor and method for treatment of related diseases
09/03/2014EP2772485A1 Bicyclic compound
09/03/2014EP2772484A1 Bicyclic heterocyclic compound
09/03/2014EP2772482A1 Azole derivative
09/03/2014EP2772481A1 Novel compound as kcnq potassium channel agonist, preparation method therefor and use thereof
09/03/2014EP2772480A1 Hiv replication inhibitor
09/03/2014EP2772260A2 Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
09/03/2014EP2772259A1 Method for isolating small molecules with important biological activity using yeast
09/03/2014EP2772258A1 Ophthalmic compositions comprising povidone-iodine
09/03/2014EP2772257A1 Formulations of quinolinones
09/03/2014EP2772256A1 Compositions for retarding weight gain associated with use of atypical antipsychotic drugs
09/03/2014EP2772255A1 Composition comprising syringaresinol for improving the skin
09/03/2014EP2772254A2 Novel Antibacterial Agents
09/03/2014EP2772253A1 Topical formulations useful for treating gagging reflex
09/03/2014EP2772252A1 Oxybutynin-containing transdermal absorption preparation
09/03/2014EP2772250A1 Enteric composition for the manufacture of soft capsule wall
09/03/2014EP2772249A1 Method and composition for treating ocular hypertension and glaucoma
09/03/2014EP2772248A1 Pharmaceutical composition and kit for treating bacterial infections
09/03/2014EP2772245A1 Ginger extract for the protection of stem cells
09/03/2014EP2772136A1 Methods for treating a variety of diseases and conditions, and compounds useful therefor
09/03/2014EP2772135A2 Medium chain peroxycarboxylic acid compositions
09/03/2014EP2772134A2 Medium chain peroxycarboxylic acid compositions
09/03/2014EP2771466A1 Inhibition of viral gene expression
09/03/2014EP2771464A2 Methods of treating cancer
09/03/2014EP2771348A1 Sialic acid analogs
09/03/2014EP2771345A1 Fused bicyclic oxazolidinone cetp inhibitor
09/03/2014EP2771343A1 Methyltransferase inhibitors for treating cancer
09/03/2014EP2771341A1 Novel compositions and methods for treating cancer
09/03/2014EP2771340A1 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
09/03/2014EP2771338A2 1, 2, 4 - oxadiazole derivatives as ethr inhibitors for use in the treatment tuberculosis
09/03/2014EP2771337A1 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh
09/03/2014EP2771336A1 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
09/03/2014EP2771335A2 (4-phenylimidazol-2-yl) ethylamine derivatives useful as sodium channel modulators
09/03/2014EP2771334A1 Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies
09/03/2014EP2771332A1 Hiv protease inhibitors
09/03/2014EP2771329A1 Novel disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated diseases
09/03/2014EP2771327A1 Novel pyrazine derivatives
09/03/2014EP2771326A1 Synthesis of triazolopyrimidine compounds
09/03/2014EP2771325A1 Pyridazine derivatives useful in therapy
09/03/2014EP2771324A1 Myxovirus therapeutics, compounds, and uses related thereto
09/03/2014EP2771322A2 Novel trpv3 modulators
09/03/2014EP2771321A1 Hydroxamate derivatives for hdac inhibitor, and the pharmaceutical composition comprising thereof
09/03/2014EP2771320A1 Cyclohexylamines
09/03/2014EP2771318A1 Novel esters of n-acyl derivatives of amino acids and diols, method for preparing same, and use thereof in cosmetics and as a drug
09/03/2014EP2771316A1 Compounds for the treatment of influenza
09/03/2014EP2771313A1 1-cycloalkyl- or 1-heterocyclyl-hydroxyimino-3-phenyl-propanes
09/03/2014EP2771241A2 New a-prp medical device&tissue engineering composition, manufacturing machines and process
09/03/2014EP2771069A2 Inhibiting g protein coupled receptor 6 kinase polypeptides
09/03/2014EP2771040A1 Nonaqueous compositions for bone hemostasis, and methods for their use and manufacture
09/03/2014EP2771036A2 Cystic fibrosis treatment
09/03/2014EP2771024A1 Treatment protocol of diabetes type 2
09/03/2014EP2771018A1 Lipid conjugates in the treatment of chronic rhinosinusitis
09/03/2014EP2771017A1 A method of treating mucus hypersecretion
09/03/2014EP2771016A1 Primycin and components thereof for use in the treatment or prevention of infections caused by specific pathogens
09/03/2014EP2771015A1 Carbonic anhydrase inhibitors and method of their production
09/03/2014EP2771014A1 Pharmaceutical composition for elimination of cancer stem cells
09/03/2014EP2771013A1 Topical pharmaceutical compositions comprising acyclovir
09/03/2014EP2771012A1 New compounds
09/03/2014EP2771011A1 Chemical compounds
09/03/2014EP2771009A1 Compounds for inflammation and immune-related uses
09/03/2014EP2771008A1 MACROCYCLES THAT INCREASE p53 ACTIVITY AND THE USES THEREOF
09/03/2014EP2771007A1 Treatment of rhinitis
09/03/2014EP2771006A1 Process for making beta 3 angonists and intermediates
09/03/2014EP2771005A1 Inhibitors of the renal outer medullary potassium channel
09/03/2014EP2771004A1 Inhibitors of the renal outer medullary potassium channel
09/03/2014EP2771003A1 Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
09/03/2014EP2771002A1 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydromorphone, prodrugs, methods of making and use thereof
09/03/2014EP2771001A1 Piperidinyl alkyne orexin receptor antagonists
1 ... 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 ... 7860